Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Stolfo

Showing results (51-60 of 201) with videos related to

Pageof 21
Sort By:
European Journal of Heart Failure|July 7, 2023
Real-world use of sodium-glucose cotransporter 2 inhibitors in patients with heart failure and reduced ejection fraction: Data from the Swedish Heart Failure RegistryDavide Stolfo, Lars H Lund, Lina Benson, et al.
Journal of Cardiac Failure|August 27, 2023
Does Heterogeneity Exist in Treatment Associations With Renin-Angiotensin-System Inhibitors or Beta-blockers According to Phenotype Clusters in Heart Failure with Preserved Ejection Fraction?Alicia Uijl, Stefan Koudstaal, Davide Stolfo, et al.
Giornale Italiano Di Cardiologia (2006)|January 13, 2023
[Transcatheter devices for chronic heart failure: state of the art]Edoardo Pancaldi, Stefano Benenati, Michele Emdin, et al.
JACC. Heart Failure|June 1, 2019
Sex-Based Differences in Heart Failure Across the Ejection Fraction Spectrum: Phenotyping, and Prognostic and Therapeutic ImplicationsDavide Stolfo, Alicia Uijl, Ola Vedin, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 22, 2017
Lifelong arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy: distribution of events and impact of periodical reassessmentChiara Cappelletto, Davide Stolfo, Antonio De Luca, et al.
European Journal of Heart Failure|April 23, 2022
Transient versus persistent improved ejection fraction in non-ischaemic dilated cardiomyopathyPaolo Manca, Davide Stolfo, Marco Merlo, et al.
International Journal of Cardiology|April 30, 2016
ST-elevation myocardial infarction with reduced left ventricular ejection fraction: Insights into persisting left ventricular dysfunction. A pPCI-registry analysisDavide Stolfo, Martino Cinquetti, Marco Merlo, et al.
European Journal of Preventive Cardiology|October 11, 2023
Activities of daily living in heart failure patients and healthy subjects: when the cardiopulmonary assessment goes beyond traditional exercise test protocolsMassimo Mapelli, Elisabetta Salvioni, Irene Mattavelli, et al.
Journal of the American Heart Association|July 2, 2016
Natural History of Dilated Cardiomyopathy in ChildrenIlaria Puggia, Marco Merlo, Giulia Barbati, et al.
Heart, Lung & Circulation|August 16, 2021
STEMI and Multivessel Disease: Medical Therapy Amplifies the Benefit of Complete Myocardial RevascularisationEnrico Fabris, Andrea Pezzato, Caterina Gregorio, et al.
Pageof 21

Showing results (51-60 of 201) with videos related to

Sort By:
Pageof 21
European Journal of Heart Failure|July 7, 2023
Real-world use of sodium-glucose cotransporter 2 inhibitors in patients with heart failure and reduced ejection fraction: Data from the Swedish Heart Failure RegistryDavide Stolfo, Lars H Lund, Lina Benson, et al.
Journal of Cardiac Failure|August 27, 2023
Does Heterogeneity Exist in Treatment Associations With Renin-Angiotensin-System Inhibitors or Beta-blockers According to Phenotype Clusters in Heart Failure with Preserved Ejection Fraction?Alicia Uijl, Stefan Koudstaal, Davide Stolfo, et al.
Giornale Italiano Di Cardiologia (2006)|January 13, 2023
[Transcatheter devices for chronic heart failure: state of the art]Edoardo Pancaldi, Stefano Benenati, Michele Emdin, et al.
JACC. Heart Failure|June 1, 2019
Sex-Based Differences in Heart Failure Across the Ejection Fraction Spectrum: Phenotyping, and Prognostic and Therapeutic ImplicationsDavide Stolfo, Alicia Uijl, Ola Vedin, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 22, 2017
Lifelong arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy: distribution of events and impact of periodical reassessmentChiara Cappelletto, Davide Stolfo, Antonio De Luca, et al.
European Journal of Heart Failure|April 23, 2022
Transient versus persistent improved ejection fraction in non-ischaemic dilated cardiomyopathyPaolo Manca, Davide Stolfo, Marco Merlo, et al.
International Journal of Cardiology|April 30, 2016
ST-elevation myocardial infarction with reduced left ventricular ejection fraction: Insights into persisting left ventricular dysfunction. A pPCI-registry analysisDavide Stolfo, Martino Cinquetti, Marco Merlo, et al.
European Journal of Preventive Cardiology|October 11, 2023
Activities of daily living in heart failure patients and healthy subjects: when the cardiopulmonary assessment goes beyond traditional exercise test protocolsMassimo Mapelli, Elisabetta Salvioni, Irene Mattavelli, et al.
Journal of the American Heart Association|July 2, 2016
Natural History of Dilated Cardiomyopathy in ChildrenIlaria Puggia, Marco Merlo, Giulia Barbati, et al.
Heart, Lung & Circulation|August 16, 2021
STEMI and Multivessel Disease: Medical Therapy Amplifies the Benefit of Complete Myocardial RevascularisationEnrico Fabris, Andrea Pezzato, Caterina Gregorio, et al.
Pageof 21